欧林生物股价连续3天下跌累计跌幅10.36%，华富基金旗下1只基金持60万股，浮亏损失156万元

Group 1 - The core point of the news is that Olin Bio has experienced a decline in stock price, dropping 0.35% to 22.49 CNY per share, with a total market value of 9.129 billion CNY and a cumulative drop of 10.36% over the last three days [1] - Olin Bio's main business involves the research, production, and sales of human vaccines, with the majority of revenue coming from the adsorbed tetanus vaccine at 90.99%, followed by A and C group meningococcal polysaccharide conjugate vaccine at 4.49%, and Hib conjugate vaccine at 3.99% [1] - The company was founded on December 11, 2009, and went public on June 8, 2021, located in Chengdu, Sichuan Province [1] Group 2 - Huafu Fund has a significant holding in Olin Bio, with its Huafu Health and Entertainment Flexible Allocation Mixed A Fund (001563) holding 600,000 shares, representing 7.56% of the fund's net value, making it the fourth-largest holding [2] - The fund has incurred a floating loss of approximately 48,000 CNY today and a total floating loss of 1.56 million CNY during the three-day decline [2] - The Huafu Health and Entertainment Flexible Allocation Mixed A Fund was established on August 4, 2015, with a current scale of 50.2705 million CNY and a year-to-date return of 41.01% [2]